3 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 3 | 1 | Terminated 1 |
Follow Control group: new trials by email Literature Review of Control group trials Research Report on Control group
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer D07001-softgel capsules + Xeloda (or TS-1), mFOLFOX - Biliary Tract Cancer | Phase 2 / Phase 3 | Terminated | InnoPharmax Inc. | 19 | 2022-03-29 | 2026-11-04 |
| Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis Control group, ASA group, IBU group - Tuberculosis, Pulmonary, Tuberculosis, MDR | Phase 2 | Terminated | Fundació Institut Germans Trias i Pujol | 426 | 2021-03-04 | 2026-06-01 |
| Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection Prednisone, Control group - Viral Pneumonia Human Coronavirus, COVID-19 | Phase 2 | Terminated | Hospices Civils de Lyon | 11 | 2020-04-21 | 2020-10-26 |
Biliary Tract Neoplasms (1) · COVID-19 (1) · Communicable Diseases (1) · Latent Tuberculosis (1) · Tuberculosis (1) · Tuberculosis, Multidrug-Resistant (1) · Tuberculosis, Pulmonary (1)
Fundació Institut Germans Trias i Pujol (1) · Hospices Civils de Lyon (1) · InnoPharmax Inc. (1)
France (1) · Georgia (1) · South Africa (1) · Taiwan (1)